Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 10,019.8%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 10,019.76% |
WW International, Inc Common Stock (WW) | 2,460.31% |
DeFi Development (DFDV) | 2,141.05% |
Oncology Institute (TOI) | 1,285.62% |
Kindly (NAKA) | 1,051.61% |
SRM Entertainment, Inc Common Stock (SRM) | 997.31% |
Diginex Limited Ordinary Shares (DGNX) | 983.33% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 881.67% |
Abivax SA American Depositary Shares (ABVX) | 853.04% |
Global Interactive Technologies (GITS) | 802.49% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 794.11% |
Newegg Commerce (NEGG) | 778.38% |
Imunon (IMNN) | 761.63% |
Asset Entities Inc Class B Common Stock (ASST) | 754% |
mF International Limited Ordinary Shares (MFI) | 616.54% |
Airnet Technology (ANTE) | 612.19% |
Quantum BioPharma (QNTM) | 591.05% |
ThredUp (TDUP) | 583.33% |
Abits (ABTS) | 528.53% |
So-Young International (SY) | 487.41% |
Dominari (DOMH) | 466% |
ABVC BioPharma (ABVC) | 400% |
Vigil Neuroscience (VIGL) | 373.53% |
TMC the metals (TMC) | 369.3% |
Immunoprecise Antibodies (IPA) | 363.41% |
